Norris Medicines
₹11.72
13 May, 2024 16:05 BSE: 524414
NSE: NORRISISIN: INE744C01029
Start SIP in Norris Medicines
Start SIPNorris Medicines Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Norris Medicines Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1 | 3 | 1 | 1 |
| Operating Expenses Qtr Cr | 1 | 3 | 1 | 1 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 1 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 1 |
| Net Profit Qtr Cr | 0 | 0 | -1 | -1 |
Norris Medicines Technicals
EMA & SMA
Current Price
₹11.72
+0 (0%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹12.94
- 50 Day
- ₹14.65
- 100 Day
- ₹15.31
- 200 Day
- ₹14.76
- 20 Day
- ₹13.13
- 50 Day
- ₹15.10
- 100 Day
- ₹16.72
- 200 Day
- ₹14.28
Norris Medicines Resistance and Support
PIVOT
₹11.72
| Resistance | |
|---|---|
| First Resistance | 11.72 |
| Second Resistance | 11.72 |
| Third Resistance | 11.72 |
| RSI | 19.47 |
| MFI | 0.00 |
| MACD Single Line | -0.92 |
| MACD | -0.91 |
| Support | |
|---|---|
| First Resistance | 11.72 |
| Second Resistance | 11.72 |
| Third Resistance | 11.72 |
Norris Medicines Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 735 | 73,500 | 100 |
| Week | 601 | 60,050 | 100 |
| 1 Month | 364 | 36,350 | 100 |
| 6 Month | 2,737 | 221,118 | 80.79 |
Norris Medicines Result Highlights
Norris Medicines Synopsis
BSE-Medical-Biomed/Biotech
Norris Medicines is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 8.36 Cr. and Equity Capital is Rs. 9.93 Cr. for the Year ended 31/03/2023. Norris Medicines Ltd. is a Public Limited Listed company incorporated on 07/09/1990 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1990PLC086581 and registration number is 086581.| Market Cap | 0 |
| Sales | 5 |
| Shares in Float | 0.66 |
| No of funds | 6 |
| Yield |
| Book Value | 7.63 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | |
| Alpha | -0.02 |
| Beta | 0.65 |
Norris Medicines
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 34.01% | 34.01% | 34.01% | 34.01% |
| Mutual Funds | 0.01% | 0.01% | 0.01% | 0.01% |
| Financial Institutions/ Banks | 0.06% | 0.06% | 0.06% | 0.06% |
| Individual Investors | 20.7% | 20.66% | 20.66% | 20.62% |
| Others | 45.22% | 45.26% | 45.26% | 45.3% |
Norris Medicines Management
| Name | Designation |
|---|---|
| Mrs. Susmita Mahapatra | Woman Director |
| Mr. Shaikh Amanullah Mohamed Azmathullah | Director |
| Dr. Hiten Parikh | Director |
| Mr. Vimal Shah | Managing Director |
Norris Medicines Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Norris Medicines Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-14 | Quarterly Results | |
| 2023-12-29 | Others | Inter alia : 1. To Consider and approve Authorized Signatory for Bank Operations. 2. To Consider and recommend Mr. Vimal Shah as a Director of the Company subject to Members approval. |
| 2023-11-18 | A.G.M. | |
| 2023-11-10 | Quarterly Results | |
| 2023-08-10 | Quarterly Results |
Norris Medicines FAQs
What is Share Price of Norris Medicines ?
Norris Medicines share price is ₹11 As on 13 May, 2024 | 15:51
What is the Market Cap of Norris Medicines ?
The Market Cap of Norris Medicines is ₹11.7 Cr As on 13 May, 2024 | 15:51
What is the P/E ratio of Norris Medicines ?
The P/E ratio of Norris Medicines is -6.2 As on 13 May, 2024 | 15:51
What is the PB ratio of Norris Medicines ?
The PB ratio of Norris Medicines is -0.9 As on 13 May, 2024 | 15:51